GHK-Cu (Copper Peptide)

GHK-Cu Mechanism: What Is Actually Proposed

UKPWritten & reviewed by William Heath · Editor, UK Peptides research library2 min readLast reviewed 2026-08-233 cited sources

The short answer

The dominant mechanistic proposal is copper delivery. GHK acting as a carrier that supplies copper(II) to enzymes requiring it as a cofactor, including lysyl oxidase and superoxide dismutase. Separate reported activities include broad gene-expression modulation. No specific receptor has been established.

Key facts

Primary proposal
Copper delivery to cuproenzymes
Named enzymes
Lysyl oxidase, superoxide dismutase
Also reported
Broad gene-expression modulation
Receptor
None established
Evidence base
Predominantly in vitro
Consequence
Mechanism is inferred, not mapped

Why copper delivery is the leading account

Several enzymes require copper as a cofactor and cannot function without it. Lysyl oxidase cross-links collagen and elastin; superoxide dismutase disposes of superoxide radicals. A molecule that binds copper reversibly and with high affinity is well suited to supplying it, and that framing explains a striking amount of GHK-Cu's reported activity without needing a receptor at all.

What that explains

Reported effects on extracellular matrix biosynthesis fit neatly, since lysyl oxidase is directly involved in collagen and elastin cross-linking. Reported antioxidant activity fits through superoxide dismutase. Both are consequences of enzymes doing their normal job with adequate cofactor rather than of a novel signalling event.

Research material referenced

GHK-Cu 100mg, third-party HPLC tested

Buy GHK-Cu · £34.99

What it does not explain

Modulation of thousands of genes is not obviously a copper-delivery effect, and the reported interactions with growth-factor signalling are not either. Either GHK has activity beyond copper transport, or copper availability has consequences broader than the two named enzymes suggest. The literature does not settle which, and both may be partly true.

The missing receptor

No specific GHK receptor has been characterised. That is less damaging here than for a compound like DSIP, because copper delivery provides a coherent mechanism that does not require one. A carrier does not need a receptor to deliver its cargo. But it does mean the non-copper activities are described rather than explained, and cannot be tested by the usual pharmacological methods.

The matrikine framing

GHK is sometimes described as a matrikine. A peptide fragment released from extracellular matrix proteins that signals back to cells. The framing is appealing and connects the compound to matrix biology, but it should be read as a proposed category rather than a demonstrated mechanism, since it too depends on signalling that has not been mapped to a receptor.

How to weigh it

Copper delivery is a plausible, chemically grounded mechanism supported by the compound's most reliable property. That it binds copper. Everything beyond it is more loosely connected. A mechanism that explains part of the literature well and part of it not at all is a normal state for a compound of this age, and it is more useful to say so than to present a unified account the evidence does not support.

Frequently asked questions

Does GHK-Cu have a receptor?

None has been established. The dominant mechanism (copper delivery) does not require one, but the other reported activities are unexplained without it.

Which enzymes does it supply copper to?

Lysyl oxidase, involved in collagen and elastin cross-linking, and superoxide dismutase, which disposes of superoxide radicals, are the two most often named.

Is the copper or the peptide doing the work?

The leading account attributes much of it to copper delivery, which makes the peptide the carrier rather than the active agent. It does not account for all reported effects.

Continue researching

Peer-reviewed guides, comparators and matched reference materials.

Primary sources & clinical trials

Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.

Browse the wider literature

Live database searches, not fixed citations. Results change as new work is indexed.

UKP

Written and reviewed by

William Heath · Editor, UK Peptides research library

William Heath edits the UK Peptides research library. He is responsible for what is published here: every article is sourced to primary literature, every purity or identity statement traces to a signed third-party certificate for a specific lot, and corrections are made in place with the review date updated. No scientific or medical credentials are claimed on this site; the evidence is carried by the cited sources and the certificates, not by the byline.

More GHK-Cu (Copper Peptide) articles

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.